A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
2022-RA-1047-ESGO Surgical restaging of early-stage endometrial cancer patients with lymphovascular invasion does not significantly impact their survival outcomes
2022
Endometrial cancer
unpublished
2022-VA-1045-ESGO Table 1 Patient charecteristics Conclusion The current evidence for SLN mapping versus LND was reviewed. ( 4, 5, 6, 7 ). Regardless of the surgical approach, SLN reduces blood loss during surgery. Further studies on operative time and complications are needed for further analysis. SLN mapping is more targeted for fewer lymph node dissections and more positive lymph node detection, even in high-risk patients. The utility of SLN does not imply adverse survival in EC patients.
doi:10.1136/ijgc-2022-esgo.283
fatcat:7eshovrmzjckha7gvinnbg2qje